Usually, fulminant, invasive fungal rhinosinusitis is observed in the immunocompromised patient and is associated with significant morbidity and mortality. A high index of suspicion and early diagnosis is imperative for optimizing outcome. Mainstays of treatment include antifungal agents and radical resection of necrotic tissue. Reversal of the underlying medical condition, when possible, is a critical part of the management. In the neutropenic population, granulocyte transfusion may represent an adjunct to current therapy. We provide the first report of a case of invasive fungal rhinosinusitis in which this intervention was used.
Get full access to this article
View all access options for this article.
References
1.
deShazoR.D., O'BrienM., ChapinK.A new classification and diagnostic criteria for invasive fungal sinusitis.Arch Otolaryngol Head Neck Surg123: 1181–1188, 1997.
2.
DenningD.W., and StevensD.A.Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases.Rev Infect Dis12: 1147–1201, 1990.
3.
ShawG.Y., PanjeW.R., CoreyJ.P.Risk factors in the development of acute sinusitis in immunocompromised patients.Am J Rhinol5: 103–108, 1991.
4.
WiatrackB.J., WillgingP., MyerC.M.Functional endoscopic sinus surgery in the immunocompromised child.Otolaryngol Head Neck Surg105: 818–825, 1991.
5.
BerlingerN.T.Sinusitis in immunodeficient and immunosup-pressed patients.Laryngoscope95: 29–33, 1985.
6.
StermanB.M.Sinus surgery in bone marrow transplantation patients.Am J Rhinol13: 315–317, 1999.
7.
JohnsonP.J., LydiattW.M., HueterJ.V.Invasive fungal sinusitis following liver or bone marrow transplantation.Am J Rhinol8: 77–83, 1994.
8.
WajszczukC.P., DummerJ.S., HoM.Fungal infections in liver transplant recipients.Transplantation40: 347–53, 1985.
9.
WaitzmanA.A., and BirtB.D.Fungal sinusitis.J Otolaryngol23: 244–249, 1994.
10.
FisherE.W., TomaA., FisherP.H.Rhinocerebral mucormycosis: use of liposomal amphotericin B.J Laryngol Otol105: 575–577, 1991.
11.
Rodriguez-AdrianL.J., GrazziuttiM.L., RexJ.H.The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?Clin Infect Dis26: 1270–1278, 1998.
12.
KeiserP., RademacherS., SmithJ.W.Granulocyte colony-stimulating factor use is associated with decreased bacteremia and increased survival in neutropenic HIV-infected patients.Am J Med104: 48–55, 1998.
13.
GillespieM.B., O'MalleyB.W.Jr., and FrancisH.W.An approach to fulminant invasive fungal rhinosinusitits in the immuncom-promised host.Arch Otolaryngol Head Neck Surg124: 520–526, 1998.
14.
PetersC., MinkovM., Matthes-MartinS.Leukocyte transfusion from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients.Br J Heme106: 689–696, 1999.
